Ankush Kumar’s journey at ProcDNA takes another step forward as he takes on the role of 

, reflecting his continued professional growth, leadership, and contributions to the organization.

Over the course of his journey with ProcDNA, Ankush has contributed to client engagements, supported teams, and helped drive meaningful outcomes across the life sciences industry. His experience and commitment have enabled him to build strong expertise while taking on increasing responsibilities and contributing to the organization’s growth.

His progression also reflects ProcDNA’s focus on creating opportunities for internal growth and recognizing the capabilities and contributions of its people. By providing team members with opportunities to take on broader responsibilities, ProcDNA continues to foster a culture of learning, leadership, and professional development.

In his new role as Delivery Partner, Ankush will continue to bring his experience and leadership to strengthen delivery capabilities, support teams, and build deeper client partnerships. He will also contribute to driving collaboration, addressing complex client needs, and delivering impactful solutions across the life sciences ecosystem.

As ProcDNA continues to grow globally, Ankush’s expanded role will further support the organization’s efforts to strengthen its teams, deepen client relationships, and create greater value for clients.

This next step in Ankush’s journey represents not only his individual growth, but also ProcDNA’s continued commitment to developing its people and creating opportunities for them to make a greater impact.

We look forward to seeing Ankush continue to grow, lead, and contribute to ProcDNA’s journey ahead.



Ankush Kumar Steps into the Role of Delivery Partner at ProcDNA

ProcDNA has expanded its presence with the inauguration of a new office in Bengaluru, marking another significant milestone in the company’s continued growth and expanding global footprint.

The new office has been designed to create a collaborative and connected work environment, bringing teams together to exchange ideas, share knowledge, and foster stronger cross-functional collaboration. The space provides an environment where employees can connect, engage in meaningful discussions, and work together more effectively to address evolving challenges across the life sciences industry.

The Bengaluru office will also serve as an important hub for strengthening collaboration across ProcDNA’s teams and geographies. By creating greater opportunities for teams to interact and share perspectives, the new location is expected to support knowledge exchange, innovation, and the development of new ideas and approaches.

The expansion comes as ProcDNA continues to grow its capabilities and presence across key global markets. With the life sciences industry undergoing rapid transformation, the company remains focused on combining domain expertise, data, analytics, and technology to help clients navigate complex business challenges and make more informed decisions.

The new Bengaluru office reflects ProcDNA’s continued investment in its people and its commitment to creating an environment that supports collaboration, innovation, and professional growth. It also reinforces the company’s vision of building stronger connections across its global teams while remaining close to the clients and markets it serves.

As ProcDNA continues its growth journey, the Bengaluru office is expected to play an important role in supporting the company’s evolving needs and creating new opportunities for collaboration, innovation, and value creation across the life sciences ecosystem.

The inauguration marks not just the opening of a new workplace, but another step forward in ProcDNA’s journey of growth — bringing together people, ideas, and opportunities to shape the future of life sciences consulting.



ProcDNA Expands Its Presence with the Inauguration of a New Office in Bangalore

The ProcDNA company has been awarded the 

Best Life Sciences AI & Data Strategy Consultancy San Francisco 2026

 award from Business Circle. This is indicative of the fact that ProcDNA remains committed to making a difference through data across the life sciences sector.
Founded in 2020, ProcDNA has evolved to become a global analytics and technology consultancy that serves some of the best pharmaceuticals and biotech's in the world. With over 

, ProcDNA combines industry expertise with cutting-edge technology to empower commercial and clinical decision-making.

, the company's own proprietary portfolio which aims to provide HCP 360 solutions and better HCP and KOL engagement through intelligent solutions. The unique method employed by the company, involving analytics and implementation, has been one that has always made ProcDNA stand out in an industry where there has always been a wide disconnect between analysis and execution. The recognition by Business Circle adds even more validation to the company's status as one of the leaders in data and AI strategies for the life sciences industry.

Partner and Founding Member, ProcDNA

"This recognition reflects the work our teams put in everyday building solutions that are not just technically sound, but genuinely useful for the people making critical decisions in life sciences."

ProcDNA Named Best Life Sciences AI & Data Strategy Consultancy San Francisco 2026 by Business Circle

Biopharma Medical Affairs Nexus Conference 2026

 are transforming scientific engagement across the Medical Affairs ecosystem from strategic planning and HCP engagement to generating actionable post-engagement insights.

As the role of Medical Affairs continues to evolve, the session highlighted how data-driven decision-making, AI-powered intelligence, and connected insights can help organizations enhance scientific exchange, improve engagement effectiveness, and deliver greater value to stakeholders.

The conference provided an excellent platform to connect with Medical Affairs leaders, exchange ideas, and discuss the future of scientific engagement, innovation, and digital transformation across the life sciences industry.

ProcDNA at the Biopharma Medical Affairs Nexus Conference 2026

ProcDNA participated in the Pharmaceutical Management Science Association (PMSA) Annual Conference 2026 in New Orleans, bringing together pharmaceutical, biotechnology, and analytics leaders to discuss how AI, data, and advanced analytics are reshaping decision-making across the life sciences industry.

Varsha Eluri, Supriye Jain, Rohit Madaan, and Akanksha Nangia

 engaged with industry leaders through insightful discussions, a podium presentation, and poster sessions focused on advancing AI-driven decision intelligence across commercial and medical functions.

At the conference, ProcDNA showcased practical applications of AI that help life sciences organizations move beyond isolated pilots to enterprise-scale adoption. The team's sessions highlighted how organizations can operationalize generative AI and agentic systems to improve content discoverability, strengthen field execution, accelerate insight generation, and enable faster, more informed business decisions.

The conference also provided an opportunity to exchange perspectives with industry peers on the evolving role of AI in commercial analytics, market access, medical affairs, and customer engagement. As organizations continue to invest in data-driven transformation, discussions reinforced the importance of combining deep domain expertise with scalable AI capabilities to deliver measurable business impact.

ProcDNA remains committed to helping life sciences organizations translate data into action through AI-powered solutions that enable smarter decision-making, improve operational efficiency, and accelerate commercial success.

ProcDNA at PMSA Annual Conference 2026

Ashish Agrawal, Adyant Jha, Varsha Eluri, and Akanksha Nangia

 engaged with commercial, medical, and analytics leaders from across the pharmaceutical industry.A key theme throughout the event was the industry's shift from generating insights to driving real-world execution. Discussions explored how organizations are moving beyond dashboards and analytics to operationalize data-driven decisions across product launches, HCP engagement, patient access, and commercial strategy. It was a valuable opportunity to exchange perspectives on how Data and AI can help accelerate this transformation and create measurable business impact across the life sciences ecosystem.


Inside Reuters Pharma USA 2026 with ProcDNA

ProcDNA recently conducted an engaging leadership session at the 

Indian Institute of Management (IIM) Sambalpur

 delivered a masterclass on careers and opportunities in life sciences consulting.

The session provided students with a practical understanding of the evolving life sciences consulting landscape, highlighting how data, analytics, and strategic decision-making are transforming the pharmaceutical and healthcare industries. Drawing on real-world consulting experience, Harpreet Singh shared insights into the challenges organizations face and the role consultants play in helping clients navigate complex business decisions.

Students were introduced to the key functional areas within pharmaceutical consulting, including commercialization, market access, analytics, competitive intelligence, and digital transformation. The discussion also explored the skills, mindset, and problem-solving approach required to build a successful consulting career in the life sciences sector.

A key focus of the session was ProcDNA's approach to combining deep domain expertise with advanced analytics and technology to solve real-world business challenges. Students gained valuable perspectives on how the company supports pharmaceutical and biotechnology organizations in making data-driven decisions that improve commercial performance and healthcare outcomes.

The masterclass concluded with an interactive question-and-answer session, where students actively engaged with the speaker on career pathways, industry trends, and the future of consulting in the age of AI and data-driven innovation.

ProcDNA remains committed to collaborating with leading academic institutions to bridge the gap between classroom learning and industry practice. Through campus engagement initiatives, the company continues to inspire and prepare the next generation of business leaders for careers in life sciences consulting.

ProcDNA Engages Future Life Sciences Leaders through Masterclass at IIM Sambalpur

 as part of its Corporate Social Responsibility (CSR) initiatives, reaffirming its commitment to supporting community health and encouraging employees to contribute to a meaningful social cause.

, the initiative brought together employees who voluntarily donated blood to help strengthen local blood supplies and support patients in need of lifesaving transfusions.

The blood donation camp reflects ProcDNA's belief that creating a positive impact extends beyond business outcomes. By fostering a culture of social responsibility and volunteerism, the company continues to encourage its teams to participate in initiatives that contribute to the well-being of the communities in which it operates.

Employee participation played a key role in the success of the drive, with volunteers demonstrating their commitment to making a tangible difference through a simple yet impactful act of giving. The event also served as an opportunity to raise awareness about the ongoing need for regular blood donations and the critical role donors play in supporting healthcare systems.

At ProcDNA, community engagement remains an integral part of the organization's values. Through CSR programs focused on health, education, and social impact, the company strives to create sustainable value beyond its work in the life sciences industry.

ProcDNA extends its gratitude to the participating employees, the organizing partners, and everyone who contributed to making the blood donation drive a success. The company remains committed to supporting initiatives that promote community welfare and inspire collective action for a healthier future.

ProcDNA Organizes Blood Donation Drive as Part of its Ongoing CSR Commitment

Pharma Market Research Conference (PMRC) 2026

 connected with market research, commercial, and insights leaders to discuss the evolving landscape of pharmaceutical market research and its growing role in driving strategic business decisions.

Throughout the conference, discussions emphasized how market research is evolving beyond traditional reporting to become a critical enabler of commercial planning, brand strategy, and customer-centric decision-making. Industry experts explored how organizations are leveraging advanced analytics, AI, and real-world evidence to uncover deeper market insights, anticipate changing customer needs, and navigate increasingly complex competitive environments.

ProcDNA shared perspectives on how data-driven intelligence and analytics can help pharmaceutical organizations make more informed decisions across the product lifecycle. Conversations also highlighted the importance of integrating multiple data sources, generating actionable insights, and enabling faster, evidence-based strategies that improve commercial performance and business outcomes.

The conference provided a valuable opportunity to exchange ideas with industry peers, explore emerging trends shaping the future of pharmaceutical market research, and strengthen collaborations across the life sciences community. It reinforced ProcDNA's commitment to empowering organizations with innovative data, AI, and analytics solutions that transform market insights into measurable business impact.


ProcDNA at PMRC 2026: From Insights to Strategy

ProcDNA is proud to announce that it has become an 

, reinforcing its commitment to helping life sciences organizations accelerate digital transformation across commercial, medical, and clinical functions.

The partnership combines ProcDNA's expertise in life sciences consulting, data, analytics, and technology with Veeva's industry-leading cloud solutions, enabling pharmaceutical and biotechnology companies to implement scalable, compliant, and execution-focused digital initiatives.

As an Official Veeva Services Partner, ProcDNA will support organizations across a wide range of strategic and operational initiatives, including platform implementation, data management, systems integration, analytics, and ongoing optimization. The collaboration is designed to help clients modernize their technology ecosystems while improving operational efficiency and enabling better business outcomes.

 to streamline commercial, medical, and clinical operations.

Master Data Management (MDM) and core data foundation

 services to improve data quality and governance.

 to connect enterprise applications and simplify workflows.

Application support and continuous optimization

By combining deep domain expertise with proven implementation capabilities, ProcDNA helps life sciences organizations unlock greater value from their Veeva investments while ensuring scalability, compliance, and operational excellence.

This milestone further strengthens ProcDNA's growing ecosystem of strategic technology partnerships and reflects the company's continued focus on delivering end-to-end digital solutions tailored to the evolving needs of the life sciences industry.

As organizations continue to modernize their commercial and clinical operations, ProcDNA remains committed to helping clients leverage technology, data, and analytics to drive innovation, improve execution, and achieve sustainable growth.



ProcDNA becomes an Official Veeva Services Partner to Accelerate Digital Transformation in Life Sciences

, marking six years of helping life sciences organizations make better decisions through data, analytics, AI, and strategic consulting. Since its inception, the company has grown from a focused vision into a global organization serving pharmaceutical and biotechnology companies across multiple markets.

Over the past six years, ProcDNA has expanded its global footprint to 

more than 400 professionals across eight locations

, supporting clients throughout the commercial and clinical value chain. By combining deep life sciences expertise with advanced analytics and technology, the company has enabled organizations to navigate increasingly complex business challenges and accelerate decision-making.

Throughout its journey, ProcDNA has built long-term partnerships with leading life sciences organizations, delivering solutions across research and development, commercialization, market access, sales effectiveness, competitive intelligence, and AI-driven analytics. This sustained growth has been fueled by a commitment to innovation, client success, and a collaborative culture that empowers teams to solve complex, real-world problems.

The anniversary also recognizes the people who have shaped ProcDNA's journey—from employees and leaders to clients and partners who have contributed to the company's continued success. As the organization reflects on its achievements, it remains focused on fostering a culture of learning, collaboration, and continuous improvement.

Looking ahead, ProcDNA plans to further strengthen its capabilities in artificial intelligence, advanced analytics, and digital transformation while expanding its global presence to meet the evolving needs of the life sciences industry.

As it enters its next phase of growth, ProcDNA remains committed to helping organizations transform data into actionable insights, drive innovation, and ultimately improve healthcare outcomes worldwide.

ProcDNA Celebrates Six Years of Growth, Innovation, and Impact in Life Sciences

 capabilities, designed to help life sciences organizations maximize the value of major scientific and medical conferences throughout the year. Covering a broad spectrum of therapeutic areas, the initiative enables pharmaceutical and biotech teams to stay ahead of emerging research, competitive developments, and evolving market dynamics.

Scientific congresses continue to play a pivotal role in shaping clinical practice, influencing treatment strategies, and driving innovation. From breakthrough clinical trial data to competitive pipeline updates, these events provide valuable opportunities for organizations to monitor trends and make informed strategic decisions.

ProcDNA's Conference Intelligence capabilities span leading events across multiple therapeutic areas, including 

Oncology, Neurology, Dermatology, Gynaecology, Cardiology, and Endocrinology

. By combining AI-powered analytics, social listening, scientific intelligence, and competitive insights, ProcDNA helps organizations transform conference activity into actionable business intelligence.

The solution supports commercial, medical affairs, market access, and competitive intelligence teams by providing:

 of conference discussions and scientific presentations.

 on product pipelines, clinical trial results, and market developments.

 to identify influential voices and engagement trends.

 to measure conference conversations and audience sentiment.

 that support strategic planning before, during, and after major congresses.

By helping organizations prepare before conferences begin and rapidly analyze emerging developments during the events, ProcDNA enables teams to respond more effectively to changing scientific and commercial landscapes.

As the 2026 conference calendar unfolds, ProcDNA remains committed to empowering life sciences organizations with timely, data-driven intelligence that supports innovation, informed decision-making, and improved patient outcomes.

ProcDNA Showcases 2026 Conference Intelligence Capabilities across Key Life Sciences Therapeutic Areas

ProcDNA has announced the inauguration of its expanded office in 

, marking another milestone in the company's growth journey. The new workspace reflects ProcDNA's continued investment in creating an environment that fosters collaboration, innovation, and professional development as the organization scales its global operations.

, alongside team members who gathered to celebrate the opening of the new office. The expansion underscores ProcDNA's commitment to supporting its growing workforce while strengthening its presence in one of India's leading business and technology hubs.

Designed to encourage creativity and teamwork, the new office offers modern collaborative spaces that bring employees together to solve complex challenges for global life sciences organizations. Beyond providing additional workspace, the facility is intended to support a culture of learning, innovation, and shared success.

The celebration brought together employees to commemorate the occasion, recognizing the collective efforts that have contributed to ProcDNA's continued growth. The event served as a reminder of the company's people-first culture and its focus on building an engaging workplace where teams can thrive.

The office expansion represents another step in ProcDNA's broader growth strategy as the company continues to expand its capabilities in AI, analytics, consulting, and technology solutions for the life sciences industry.

As ProcDNA continues its growth journey, the new Gurugram office will serve as a hub for collaboration, innovation, and talent development, supporting the company's mission to deliver transformative solutions for clients worldwide.



ProcDNA expands its Gurugram Presence with the Inauguration of a New Office

As the global hematology community prepares for the 

67th American Society of Hematology (ASH) Annual Meeting & Exposition

, ProcDNA is set to provide timely, actionable insights that help life sciences organizations stay ahead of the latest scientific and commercial developments.

Orange County Convention Center in Orlando, Florida

, ASH 2025 is expected to feature groundbreaking research, clinical trial updates, and emerging therapies that will shape the future of hematology and blood cancer care.

Recognizing that valuable conference learnings extend far beyond the event itself, ProcDNA will be tracking the most impactful announcements, scientific presentations, and industry trends to help organizations transform information into strategic action.

Leveraging its expertise in competitive intelligence, social listening, and advanced analytics, ProcDNA will deliver curated insights that enable pharmaceutical and biotech teams to monitor evolving treatment landscapes, competitor activity, key opinion leader (KOL) engagement, and emerging market dynamics.

Organizations looking to strengthen their conference intelligence and social listening capabilities can also connect with ProcDNA's experts to explore customized insight solutions tailored to their therapeutic areas and business objectives.

Through its AI-powered analytics and life sciences expertise, ProcDNA remains committed to helping organizations make faster, more informed decisions by turning complex scientific data into meaningful business intelligence.

ProcDNA to Deliver Key Insights from ASH 2025 Through Real-Time Scientific Intelligence

, providing a comprehensive analysis of the scientific discussions, treatment trends, and digital engagement shaping the future of lung cancer care. Leveraging its 

 platform, the report transforms conference conversations into actionable intelligence for pharmaceutical and biotech organizations.

, the analysis highlights the topics driving the greatest attention during the European Society for Medical Oncology (ESMO) Congress 2025.

bispecific antibodies, antibody-drug conjugates (ADCs), and combination therapies

 dominated discussions, reflecting the industry's continued shift toward precision oncology. Significant attention was also given to evolving treatment approaches in 

ProcDNA's Conference Intelligence platform combines AI-powered analytics, social listening, and scientific intelligence to help life sciences organizations monitor conference engagement in real time. The platform enables commercial, medical, and competitive intelligence teams to identify emerging research trends, understand key opinion leader (KOL) influence, and measure the impact of scientific communications.

By translating large volumes of conference data into meaningful insights, ProcDNA empowers organizations to make faster, evidence-based decisions that support product strategy, clinical development, and commercial planning.

As major scientific congresses continue to shape the future of healthcare innovation, ProcDNA remains committed to delivering timely intelligence that helps life sciences organizations stay ahead of emerging opportunities and evolving market dynamics.

ProcDNA Unveils Key Insights from ESMO 2025 Highlighting the Future of Lung Cancer Treatment

pharmaceutical and medical technology (MedTech)

 industries. This strategic collaboration brings together ProcDNA's deep expertise in life sciences consulting with Xactly's leading Incentive Compensation and Sales Performance Management platform.

The partnership is designed to help life sciences organizations optimize commercial operations by delivering effective incentive compensation strategies, streamlining sales performance management, and enabling data-driven decision-making. By combining domain expertise with advanced technology, ProcDNA and Xactly aim to support clients in improving field force effectiveness and driving sustainable commercial growth.

As part of the partnership, ProcDNA will leverage its experience in commercial analytics, incentive compensation, and sales operations to implement and optimize Xactly's solutions for pharmaceutical and MedTech organizations. The collaboration will enable clients to modernize compensation processes, improve sales performance visibility, and enhance operational efficiency.

"Our collaboration with Xactly represents an important step in expanding the value we deliver to life sciences organizations," said the ProcDNA leadership team. "Together, we are committed to helping clients achieve commercial excellence through technology-enabled solutions and industry expertise."

ProcDNA extends its appreciation to the Xactly team for their trust and collaboration and looks forward to supporting customers in navigating an increasingly complex commercial landscape with scalable, innovative solutions.

ProcDNA Joins the Xactly Partner Network to Advance Commercial Excellence in Life Sciences

 at some of India's leading management and business schools, engaging with aspiring professionals through interactive discussions on consulting, analytics, and leadership.

ISB, Great Lakes Institute of Management (Gurgaon), MDI Gurgaon, IIFT, and FORE School of Management

, bringing together students eager to explore real-world business challenges and career opportunities in the life sciences consulting and analytics industry.

Designed to bridge the gap between academia and industry, the sessions offered practical perspectives on solving complex business problems using data, analytics, and strategic thinking. ProcDNA leaders shared insights from their consulting experiences, discussed industry best practices, and highlighted the skills required to thrive in today's fast-evolving business landscape.

The interactive format encouraged meaningful conversations around leadership, innovation, structured problem-solving, and the growing role of analytics in driving business decisions. Students also had the opportunity to engage directly with ProcDNA professionals, gaining valuable career guidance and a deeper understanding of the consulting profession.

The initiative reflects ProcDNA's continued commitment to nurturing future talent and building stronger connections with academic institutions. By partnering with leading campuses, the company aims to inspire the next generation of consultants and analytics professionals while contributing to the development of industry-ready talent.

ProcDNA extends its appreciation to the participating institutions, students, and company leaders who made these sessions a success and looks forward to continuing its engagement with emerging business leaders across campuses.

ProcDNA Inspires Future Business Leaders through Campus Leadership Sessions across Premier Institutes

ProcDNA is proud to announce its recognition as 

#21 on the San Francisco Business Times' 2025 Bay Area Fastest-Growing Private Companies list

. This achievement reflects the company's continued momentum, strong client partnerships, and commitment to delivering innovative data, analytics, and AI-driven solutions to the life sciences industry.

The annual ranking celebrates the Bay Area's fastest-growing private companies across five counties, recognizing organizations that have demonstrated exceptional business growth and sustained performance.

Moving up seven positions in just one year highlights ProcDNA's dedication to helping global pharmaceutical and biotech organizations accelerate commercial success through advanced analytics, AI-powered insights, and strategic decision-making.

"This recognition is a testament to the trust our clients place in us and the dedication of our talented team," said the ProcDNA leadership team. "As we continue to grow, we remain focused on delivering meaningful impact for our clients while fostering innovation, collaboration, and excellence across everything we do."

Over the past year, ProcDNA has continued expanding its global footprint, strengthening its AI and analytics capabilities, and investing in talent to support the evolving needs of the life sciences industry.

The company extends its gratitude to its employees, clients, and partners whose continued support has made this milestone possible.

As ProcDNA looks ahead, it remains committed to driving innovation, enabling data-driven transformation, and creating lasting value for healthcare organizations worldwide.



ProcDNA Climbs to #21 on the San Francisco Business Times' 2025 Bay Area Fastest-Growing Private Companies List

ProcDNA, a global analytics and technology consulting partner to the life sciences industry, has unveiled its brand-new office in 

 - marking another milestone in the company’s continued growth and commitment to building spaces that inspire innovation, collaboration, and impact.

The new office provides an open, modern environment designed to foster teamwork and creativity. With upgraded facilities and a vibrant, collaborative layout, the space reflects ProcDNA’s culture of openness and its focus on empowering teams to deliver breakthrough solutions for life sciences clients around the world.

Speaking at the ribbon-cutting ceremony, 

The launch of the new Pune office underscores ProcDNA’s commitment to investing in its people and strengthening its operational excellence across key locations worldwide. As the company continues to scale, spaces like the Pune hub will remain central to its mission of enabling better decisions through data, technology, and insight.

Partner at ProcDNA

 “This new space is more than just an office - it’s a symbol of our people-first culture. Every corner of this office was designed to encourage collaboration, celebrate innovation, and make room for the next chapter of ProcDNA’s journey.”

 Partner at ProcDNA

“Pune has always been an integral part of our story. The energy and talent here continue to drive our growth. This new space gives our teams the perfect environment to think bigger, move faster, and create even greater impact for our clients.”

ProcDNA Unveils New Pune Office, Reflecting Growth and a Culture of Collaboration

to contribute to a more sustainable future through a meaningful tree plantation drive.

The event brought together employees from across teams to plant saplings, nurture the soil, and spend a day reconnecting with nature - reflecting ProcDNA’s deep-rooted belief in giving back to the community and the planet. From muddy hands to smiling faces, the initiative served as a reminder that collective action can create lasting impact.

Through initiatives like this, ProcDNA continues to live its 

 - fostering a culture of responsibility, empathy, and action. By empowering its people to take part in sustainability efforts, ProcDNA reaffirms its commitment to driving positive change beyond business.

“At ProcDNA, sustainability isn’t just a CSR checkbox - it’s part of who we are. Every small action, like planting a tree, contributes to a much larger mission: building a future where progress and responsibility go hand in hand. Seeing our team come together for this cause was truly inspiring.”

Rooted in Purpose: ProcDNA Teams up for a Greener Tomorrow

ProcDNA, a global analytics and technology consulting partner to the life sciences industry, is proud to announce the opening of its newest office in San Diego. This expansion reflects ProcDNA’s commitment to being closer to its clients, while embedding itself in one of the nation’s most dynamic centers for biotechnology and healthcare innovation.Known globally as a hub for biotech, pharmaceuticals, and cutting-edge healthcare research, San Diego provides ProcDNA with the opportunity to deepen relationships with clients and partners, engage with the local life sciences ecosystem, and attract top talent in the region. The new office, located in La Jolla, complements ProcDNA’s existing U.S. presence, becoming the fifth office in the country and adding strategic coverage across Southern California’s fast-growing market.

 ProcDNA Partner, Chief Revenue Officer US West

"Expanding into San Diego is more than just opening a new office - it’s about strengthening the partnerships that we have cultivated here. Being in the heart of Southern California’s Life Sciences community allows us to work side-by-side with our clients, respond faster to their needs, and co-create practical solutions that actually work."

Analyst at ProcDNA

"San Diego’s energy is truly inspiring. It’s a city where innovation meets collaboration, and that’s exactly the kind of environment that pushes us to think differently and deliver better outcomes for our clients. I’m thrilled to see ProcDNA becoming part of this vibrant ecosystem."

ProcDNA Expands Footprint with New San Diego Office, Strengthening Commitment to Life Sciences Innovation

At ProcDNA, growth isn’t just measured in square footage—it’s about creating an environment where teams thrive, innovation flourishes, and delivery scales to new heights. Continuing our expansion journey, we are excited to announce the opening of our brand-new 

This new space goes beyond infrastructure—it reflects our commitment to building a 

 in everything we do. Designed to support agility, collaboration, and scale, this office marks a bold step forward in our mission to deliver cutting-edge solutions for the life sciences industry.

With a stronger footprint in Gurugram, ProcDNA is well-positioned to tap into new talent, accelerate delivery, and continue shaping the future of life sciences analytics.

Here’s to new beginnings, bigger ambitions, and an exciting journey ahead!

ProcDNA is a premier analytics and technology consulting firm dedicated to solving complex business challenges for life sciences companies. Founded in 2019, the firm has grown rapidly, with over 200 professionals across offices in the United States and India. By leveraging data analytics, artificial intelligence, and scientific expertise, ProcDNA empowers life sciences organizations to navigate market complexities, accelerate innovation, and drive strategic success.

 Co-founder & Partner at ProcDNA

"Our new Gurugram office represents more than just growth—it’s a statement of intent. We’re investing in spaces that empower our people to innovate fearlessly and deliver impact at scale. This is where bold ideas will take shape and talent will thrive."

Executive Director at ProcDNA

 "Managed Services has been a key growth pillar for us, and this new space reflects our vision to drive operational excellence, support global delivery, and build high-performing teams. Gurugram will play a central role in our next chapter of growth."

New Views: ProcDNA's Gurugram Office Gets an Upgrade

At ProcDNA, our commitment to creating meaningful impact goes far beyond analytics. Through our 

, our teams are continuously finding ways to uplift communities and give back. This quarter, our US team turned intention into action through two powerful initiatives that combined compassion, teamwork, and purpose.

From Keyboards to Crates: Supporting Food Security in the Bay Area

, our team traded keyboards for crates—volunteering to help sort and distribute food to families in need. This hands-on effort was a reminder that community support starts with showing up and pitching in.

63 Floors. One Cause. One Unstoppable Team

Taking on a different kind of challenge, our US crew participated in the 

. Climbing 63 floors wasn’t just a physical feat—it was a bold show of solidarity in the fight against blood cancers.

These initiatives are more than isolated acts of service—they represent 

, we strive to build lasting relationships with organizations that are doing vital work, and support causes that align with our mission to create global impact.

 is the firm’s global Corporate Social Responsibility initiative, focused on driving change in the areas of education, healthcare access, and community development. From the Bay Area to India, our teams are united by one purpose: to make a difference that lasts.

Director at ProcDNA

"It’s humbling to contribute to organizations making such a real difference on the ground. These moments help us reconnect with our communities and reinforce what service truly means."

"Participating in the Big Climb was more than a physical challenge—it was a powerful reminder of the strength we have when we come together for a cause. Supporting the Leukemia & Lymphoma Society aligns with our mission to drive meaningful change both in healthcare and in the community."

Climbing Higher, Giving Back: ProcDNA US Team Puts PROMISE into Action

 engaged with pharmaceutical analytics and commercial leaders, showcasing the latest advancements in predictive modeling, Master Data Management (MDM), and HCP engagement strategies.

Throughout the summit, conversations emphasized the growing importance of connected, high-quality data as the foundation for informed commercial decision-making. Industry leaders discussed the need for integrated data ecosystems that enable organizations to improve agility, enhance operational efficiency, and respond effectively to an evolving healthcare landscape.

ProcDNA shared how its expertise in predictive analytics, Master Data Management, and AI-powered solutions is helping pharmaceutical organizations transform complex data into actionable insights. Discussions also explored strategies for delivering more personalized HCP engagement, optimizing commercial performance, and supporting data-driven decision-making across the product lifecycle.

The summit provided a valuable opportunity to exchange perspectives with peers on emerging trends in pharmaceutical analytics, the expanding role of AI, and the future of predictive intelligence in the life sciences industry. It reinforced ProcDNA's commitment to empowering pharmaceutical organizations with scalable, technology-enabled solutions that drive measurable business outcomes and accelerate commercial excellence.

Discover what’s New at ProcDNA